XML 109 R83.htm IDEA: XBRL DOCUMENT v3.25.1
Related Parties - Restricted Stock Program (Detail)
R$ / shares in Units, R$ in Thousands
 12 Months Ended
Dec. 31, 2024
BRL (R$)
shares
R$ / shares
Disclosure of transactions between related parties [line items]  
Number of shares granted (Quantity) | shares 18,521,704
Total exercisable grant costs, including taxes R$ 622,792
Accumulated recognized exercisable grant costs (183,017)
Unrecognized exercisable grant costs (in R$ thousands) R$ 439,775
Restricted Stock Award [Member] | Grant Date, September 2, 2019 [Member]  
Disclosure of transactions between related parties [line items]  
Grant date September 2, 2019
Number of shares granted (Quantity) | shares 240,000
Vesting period 2025
Fair value of shares on the grant date (in R$ per share) | R$ / shares R$ 16.42
Total exercisable grant costs, including taxes R$ 6,774
Accumulated recognized exercisable grant costs (6,024)
Unrecognized exercisable grant costs (in R$ thousands) R$ 750
Restricted Stock Award [Member] | Grant Date, April 1, 2020 [Member]  
Disclosure of transactions between related parties [line items]  
Grant date April 1, 2020
Number of shares granted (Quantity) | shares 39,084
Vesting period 2025
Fair value of shares on the grant date (in R$ per share) | R$ / shares R$ 12.53
Total exercisable grant costs, including taxes R$ 1,124
Accumulated recognized exercisable grant costs (1,074)
Unrecognized exercisable grant costs (in R$ thousands) R$ 50
Restricted Stock Award [Member] | Grant Date, September 16, 2020 [Member]  
Disclosure of transactions between related parties [line items]  
Grant date September 16, 2020
Number of shares granted (Quantity) | shares 140,000
Vesting period 2026
Fair value of shares on the grant date (in R$ per share) | R$ / shares R$ 23.03
Total exercisable grant costs, including taxes R$ 5,464
Accumulated recognized exercisable grant costs (3,946)
Unrecognized exercisable grant costs (in R$ thousands) R$ 1,518
Restricted Stock Award [Member] | Grant Date, September 22, 2021 [Member]  
Disclosure of transactions between related parties [line items]  
Grant date September 22, 2021
Number of shares granted (Quantity) | shares 1,000,000
Vesting period 2027
Fair value of shares on the grant date (in R$ per share) | R$ / shares R$ 14.17
Total exercisable grant costs, including taxes R$ 24,093
Accumulated recognized exercisable grant costs (13,339)
Unrecognized exercisable grant costs (in R$ thousands) R$ 10,754
Restricted Stock Award [Member] | Grant Date, April 6, 2022 [Member]  
Disclosure of transactions between related parties [line items]  
Grant date April 6, 2022
Number of shares granted (Quantity) | shares 634,165
Vesting period 2025
Fair value of shares on the grant date (in R$ per share) | R$ / shares R$ 14.16
Total exercisable grant costs, including taxes R$ 16,906
Accumulated recognized exercisable grant costs (15,508)
Unrecognized exercisable grant costs (in R$ thousands) R$ 1,398
Restricted Stock Award [Member] | Grant Date, September 21, 2022 [Member]  
Disclosure of transactions between related parties [line items]  
Grant date September 21, 2022
Number of shares granted (Quantity) | shares 2,640,000
Vesting period 2032
Fair value of shares on the grant date (in R$ per share) | R$ / shares R$ 12.98
Total exercisable grant costs, including taxes R$ 64,048
Accumulated recognized exercisable grant costs (14,945)
Unrecognized exercisable grant costs (in R$ thousands) R$ 49,103
Restricted Stock Award [Member] | Grant Date, December 7, 2022 [Member]  
Disclosure of transactions between related parties [line items]  
Grant date December 7, 2022
Number of shares granted (Quantity) | shares 1,500,000
Vesting period 2032
Fair value of shares on the grant date (in R$ per share) | R$ / shares R$ 13.47
Total exercisable grant costs, including taxes R$ 37,711
Accumulated recognized exercisable grant costs (7,860)
Unrecognized exercisable grant costs (in R$ thousands) R$ 29,851
Restricted Stock Award [Member] | Grant Date, April 20, 2023 [Member]  
Disclosure of transactions between related parties [line items]  
Grant date April 20, 2023
Number of shares granted (Quantity) | shares 311,324
Vesting period 2025
Fair value of shares on the grant date (in R$ per share) | R$ / shares R$ 14.5
Total exercisable grant costs, including taxes R$ 7,472
Accumulated recognized exercisable grant costs (6,538)
Unrecognized exercisable grant costs (in R$ thousands) R$ 934
Restricted Stock Award [Member] | Grant Date, April 20, 2023 [Member]  
Disclosure of transactions between related parties [line items]  
Grant date April 20, 2023
Number of shares granted (Quantity) | shares 1,146,194
Vesting period 2026
Fair value of shares on the grant date (in R$ per share) | R$ / shares R$ 14.5
Total exercisable grant costs, including taxes R$ 31,039
Accumulated recognized exercisable grant costs (18,129)
Unrecognized exercisable grant costs (in R$ thousands) R$ 12,910
Restricted Stock Award [Member] | Grant Date, September 20, 2023 [Member]  
Disclosure of transactions between related parties [line items]  
Grant date September 20, 2023
Number of shares granted (Quantity) | shares 3,800,000
Vesting period 2033
Fair value of shares on the grant date (in R$ per share) | R$ / shares R$ 18.75
Total exercisable grant costs, including taxes R$ 132,784
Accumulated recognized exercisable grant costs (17,712)
Unrecognized exercisable grant costs (in R$ thousands) R$ 115,072
Restricted Stock Award [Member] | Grant Date April 17 2024 [Member]  
Disclosure of transactions between related parties [line items]  
Grant date April 17, 2024
Number of shares granted (Quantity) | shares 3,495,953
Vesting period 2027 to 2029
Fair value of shares on the grant date (in R$ per share) | R$ / shares R$ 26.94
Total exercisable grant costs, including taxes R$ 177,651
Accumulated recognized exercisable grant costs (31,656)
Unrecognized exercisable grant costs (in R$ thousands) R$ 145,995
Restricted Stock Award [Member] | Grant Date June 19 2024 [Member]  
Disclosure of transactions between related parties [line items]  
Grant date June 19, 2024
Number of shares granted (Quantity) | shares 60,683
Vesting period 2027
Fair value of shares on the grant date (in R$ per share) | R$ / shares R$ 21.47
Total exercisable grant costs, including taxes R$ 2,468
Accumulated recognized exercisable grant costs (411)
Unrecognized exercisable grant costs (in R$ thousands) R$ 2,057
Restricted Stock Award [Member] | Grant Date October 1 2024 [Member]  
Disclosure of transactions between related parties [line items]  
Grant date October 1, 2024
Number of shares granted (Quantity) | shares 1,295,000
Vesting period 2034
Fair value of shares on the grant date (in R$ per share) | R$ / shares R$ 23.1
Total exercisable grant costs, including taxes R$ 55,785
Accumulated recognized exercisable grant costs (1,395)
Unrecognized exercisable grant costs (in R$ thousands) R$ 54,390
Performance Stock Award [Member] | Grant Date, April 1, 2020 [Member]  
Disclosure of transactions between related parties [line items]  
Grant date April 1, 2020
Number of shares granted (Quantity) | shares 55,074
Vesting period 2025
Fair value of shares on the grant date (in R$ per share) | R$ / shares R$ 12.53
Total exercisable grant costs, including taxes R$ 1,324
Accumulated recognized exercisable grant costs (1,268)
Unrecognized exercisable grant costs (in R$ thousands) R$ 56
Performance Stock Award [Member] | Grant Date, April 6, 2022 [Member]  
Disclosure of transactions between related parties [line items]  
Grant date April 6, 2022
Number of shares granted (Quantity) | shares 1,007,324
Vesting period 2025
Fair value of shares on the grant date (in R$ per share) | R$ / shares R$ 14.16
Total exercisable grant costs, including taxes R$ 26,829
Accumulated recognized exercisable grant costs (24,802)
Unrecognized exercisable grant costs (in R$ thousands) R$ 2,027
Performance Stock Award [Member] | Grant Date, April 20, 2023 [Member]  
Disclosure of transactions between related parties [line items]  
Grant date April 20, 2023
Number of shares granted (Quantity) | shares 1,156,903
Vesting period 2026
Fair value of shares on the grant date (in R$ per share) | R$ / shares R$ 14.5
Total exercisable grant costs, including taxes R$ 31,320
Accumulated recognized exercisable grant costs (18,410)
Unrecognized exercisable grant costs (in R$ thousands) R$ 12,910